发明名称 Human arginase and pegylated human arginase and the use thereof
摘要 The present invention provides a site-directed mutated arginase and the preparation method thereof, and the use of said site-directed mutated arginase in preparing a medicament for treating an arginase-related disease. The present invention also provides a pegylated arginase and the preparation method thereof, and the use of said pegylated arginase in preparing a medicament for treating an arginase-related disease.
申请公布号 US9109218(B2) 申请公布日期 2015.08.18
申请号 US201214368507 申请日期 2012.12.23
申请人 Bio-Cancer Treatment International Ltd. (Shanghai) 发明人 Cheng Ning Man;Chen Li
分类号 C12N9/78;A61K38/50;C12N9/96 主分类号 C12N9/78
代理机构 Eagle IP Limited 代理人 Eagle IP Limited ;Lui Jacqueline C.
主权项 1. An arginase, wherein said arginase is human arginase I comprising an amino acid sequence of SEQ ID NO:1 comprising a mutation at position 45 of said SEQ ID NO:1; wherein said mutation is from cysteine to alanine; wherein said arginase has activity.
地址 Shanghai CN